# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-19-045077
Filing Date
2019-12-03
Accepted
2019-12-03 08:00:36
Documents
34
Period of Report
2019-12-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | agle-8k_20191203.htm | 8-K | 40566
2 | EX-99.1 | agle-ex991_11.htm | EX-99.1 | 35478
3 | GRAPHIC | grvrdklvpj05000013.jpg | GRAPHIC | 319195
4 | GRAPHIC | grvrdklvpj05000008.jpg | GRAPHIC | 385671
5 | GRAPHIC | grvrdklvpj05000006.jpg | GRAPHIC | 290488
6 | GRAPHIC | grvrdklvpj05000004.jpg | GRAPHIC | 225490
7 | GRAPHIC | grvrdklvpj05000007.jpg | GRAPHIC | 193614
8 | GRAPHIC | grvrdklvpj05000019.jpg | GRAPHIC | 283983
9 | GRAPHIC | grvrdklvpj05000021.jpg | GRAPHIC | 327762
10 | GRAPHIC | grvrdklvpj05000017.jpg | GRAPHIC | 286335
11 | GRAPHIC | grvrdklvpj05000003.jpg | GRAPHIC | 316794
12 | GRAPHIC | grvrdklvpj05000016.jpg | GRAPHIC | 131897
13 | GRAPHIC | grvrdklvpj05000028.jpg | GRAPHIC | 300246
14 | GRAPHIC | grvrdklvpj05000029.jpg | GRAPHIC | 241504
15 | GRAPHIC | grvrdklvpj05000023.jpg | GRAPHIC | 379044
16 | GRAPHIC | grvrdklvpj05000018.jpg | GRAPHIC | 328588
17 | GRAPHIC | grvrdklvpj05000015.jpg | GRAPHIC | 322321
18 | GRAPHIC | grvrdklvpj05000024.jpg | GRAPHIC | 314111
19 | GRAPHIC | grvrdklvpj05000002.jpg | GRAPHIC | 812466
20 | GRAPHIC | grvrdklvpj05000012.jpg | GRAPHIC | 241689
21 | GRAPHIC | grvrdklvpj05000025.jpg | GRAPHIC | 97717
22 | GRAPHIC | grvrdklvpj05000026.jpg | GRAPHIC | 246310
23 | GRAPHIC | grvrdklvpj05000009.jpg | GRAPHIC | 262023
24 | GRAPHIC | grvrdklvpj05000020.jpg | GRAPHIC | 309088
25 | GRAPHIC | grvrdklvpj05000005.jpg | GRAPHIC | 389664
26 | GRAPHIC | grvrdklvpj05000032.jpg | GRAPHIC | 88294
27 | GRAPHIC | grvrdklvpj05000027.jpg | GRAPHIC | 388237
28 | GRAPHIC | grvrdklvpj05000014.jpg | GRAPHIC | 226971
29 | GRAPHIC | grvrdklvpj05000022.jpg | GRAPHIC | 379992
30 | GRAPHIC | grvrdklvpj05000010.jpg | GRAPHIC | 270197
31 | GRAPHIC | grvrdklvpj05000030.jpg | GRAPHIC | 275643
32 | GRAPHIC | grvrdklvpj05000031.jpg | GRAPHIC | 215753
33 | GRAPHIC | grvrdklvpj05000011.jpg | GRAPHIC | 385477
34 | GRAPHIC | grvrdklvpj05000001.jpg | GRAPHIC | 252959
| Complete submission text file | 0001564590-19-045077.txt |  | 13150173

Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 191264661
SIC: 2834 Pharmaceutical Preparations